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1. Introduction 
Living systems continuously monitor and respond to the surrounding environment. These 
processes are made possible by cellular signal transduction systems. When particular 
information reaches the cell (in many cases to the surface of cells), corresponding molecular 
networks are activated to process the information. These cascade-type reactions change 
many enzymes in the cell and ultimately the enzymatic reactions taking place determine the 
cellular response. Although the system includes a large number of enzymes, protein kinases 
are the most important group of enzymes and play key roles of signal transduction events. 
The human genome encodes nearly 500 types of protein kinases (Cohen, 2001). One-third of 
all cellular proteins act as substrates of protein kinases. Therefore, the monitoring of the 
activities of protein kinases is a crucial technology not only for understanding life processes, 
but also for the development of efficient diagnostics or effective drug discovery programs. 
Modification of certain protein kinase activities will also be an important medical 
technology for therapy against many diseases. In this context, this chapter will introduce 
recent technologies that have been developed to monitor protein kinases. In addition, if we 
use the activity of the protein kinases as a tool for medical engineering, we may be able to 
control cellular function when needed. In this category, new technologies that use protein 
kinase activities for controlling transgene regulation will also be introduced. 
2. Overview of kinase assays 
The activity of protein kinases is easily detected through the incorporation of a radioactive 
phosphate to a protein or peptide substrate using 32P- or 33P-ATP (Schutkowski et al., 2004; 
Panse et al., 2004; Diks et al., 2004). Although such assays are highly sensitive and 
quantitative, there are some important drawbacks such as the requirement of a special 
facility to handle radioactive materials, production of radioactive waste, the short half-lives 
(14 days) of the radioactive phosphate, and the potential risk to health. Thus, many types of 
non-radioactive protein kinase assays have been developed. In these assays, fluorescence-
based approaches represent a promising way for high-throughput analysis of protein kinase 
activities. Alternatively, colorimetry may be easier to handle and cheaper when compared 
with fluorimetry; however, the sensitivity is generally lower. Mass spectrometry represents 
another way to monitor protein kinase activity. 
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When fluorescence techniques are used for the design of protein kinase assays, many useful 
properties of the fluorescence phenomena can be used such as fluorescence intensity, 
fluorescence polarization, fluorescence energy transfer and the fluorescence life-time. 
What is important in assay design is the ability of the system to distinguish between 
phosphorylated and non-phosphorylated forms of the substrate. An anti-phospho antibody 
is a convenient way to recognize phosphorylation of a substrate. However, antibody with 
sufficient affinity for phorsporykated Ser/Thr is not commercially available. Therefore, 
other artificial molecules such as metal complexes, polycationic polymers or beads are used 
for the recognition of phosphor-serine or –threonine. Phos-Tag (Kinoshita et al., 2006; 
Inamori et al., 2005) or Pro-Q Diamond dye (Steinberg et al., 2003) are typical examples for 
this category (Fig. 1). Phos-Tag is a zinc complex that was designed by using the alkaline 
phosphatase structure, and this compound binds to phosphor-amino acids. The molecule 
also possesses a biotin moiety so that avidin derivatives can also bind tightly. Pro-Q 
Diamond dye is a gallium complex of a fluorescent molecule. Phosphorylation of a peptide 
or protein can be detected by agarose gel electrophoresis using this probe. Instead of 
binding other molecules to the phosphorylation site, phosphorylated amino acid residues 
may be derivatized to other chemical groups by attaching a marker molecule to detect the 
phosphorylated substrate (Oda et al., 2001). 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1. Chemical structures of ProQ Diamond dye and Phos Tag 
3. Protein kinase assay with measurement of fluorescence intensity 
Probably, the simplest way of using fluorimetry in kinase assays is the design of a 
fluorescent substrate that changes its fluorescence intensity upon phosphorylation. 
However, it is not so easy to change the fluorescence intensity of a single fluorescent 
molecule through phosphorylation. The first example was an acrylodan-labeled peptide 
substrate of protein kinase C (PKC) (McIlroy et al., 1991). The molecule, Acrylodan-
CKKKKRFSFKKSFKLSGFSFKKNKK-OH, decreased its fluorescence intensity by 20% upon 
phosphorylation by PKC. The time course of the fluorescence decrease was found to 
correlate well with that of [32P]phosphate incorporation. The assay detected 0.02 nM of PKC. 
Although the assay cannot be applied to living cells, the PKC activity in a brain homogenate 
was easily detected. On the other hand,  Higashi et al, 1996. reported a cell permeable 
acrylodan-labeled peptide (syntide 2) for the detection of calcium calmodulin dependent 
kinase II (CaMKII) activity (Higashi et al., 1996). The probe was used for imaging CaMKII 
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activity in mice hippocampus slices. However, this type of assay using simply fluorescence-
labeled substrates provides only a small change in the fluorescence intensity following 
phosphorylation. Consequently, the sensitivity of this approach is generally low.  
Generally it is difficult to obtain large changes in fluorescence intensity if the fluorophore 
involves the simple labeling of a peptide. Kupcho et al, 2003. reported a unique fluorescent 
probe for the detection of protein kinase A (PKA) (Kupcho et al., 2003) (Fig. 2a). In this case,  
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(a) Molecular probe for PKA monitoring based on rhodamine 110 reported by Kupcho et al. 
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(b) Micelle-based protein kinase probe for fluorescence monitoring reported by Sun et al. 
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(c) Electrostatic complex consisting of lipid-type substrate and polyanion for kinase monitoring 
Fig. 2. Protein kinase assay with measurement of fluorescence intensity (for the comment: 
This is an original figure, although it resembles to that in our pepare published in 
Bioconjugate chemistry, 22, 1526-(2011).) 
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the substrate peptide of PKA was introduced into the both sides of rhodamine 110 through 
amide bonds. The molecule is practically non-fluorescent due to the formation of a lactone ring 
in the rhodamine structure. Peptidase degrades the peptide moieties from their amino termini. 
When the peptides were completely digested, the fluorescence of the rhodamine 110 recovers. 
However, if the peptide is phosphorylated with PKA, digestion by peptidase is inhibited at the 
phosphor-serine such that the fluorescence never recovers. This method can clearly detect 
PKA activity with an ‘on-off’ strategy; however, the molecular design is not versatile and 
therefore not suitable for many kinases. In addition, the method cannot be applied to living 
cells and in vivo. It often requires the design of a complicated probe molecule to obtain large 
changes in the fluorescence intensity with phosphorylation when using small probe molecules. 
However, if we use a molecular assembly system such as micelles or polyionic complexes, it 
becomes easier to obtain larger changes in the fluorescence intensity when probing 
phosphorylation. Sun et al. 2005 reported a micelle system for the detection of protein kinase 
activity (Sun et al., 2005) (Fig. 2b). In this system, an aliphatic chain was connected to a peptide 
substrate of a target kinase that was labeled with a fluorescent molecule. If the length of the 
hydrocarbon chain is optimized, the material forms a micelle-like assembly. The fluorescence 
is then quenched due to the concentrating of the fluorophores. However, if the substrate is 
phosphorylated by a target kinase the fluorescence intensity increases several fold because of 
the decomposition of the micelle. Phosphorylation of the peptide moiety dramatically changes 
the hydrophilic-hydrophobic balance of the alkylated peptide substrate. We also developed a 
polyion complex consisting of an alkylated cationic peptide substrate and a fluorescein-labeled 
polyaspartic acid for monitoring protein kinase A or protein kinase C activity (Koga et al. 
2011) (Fig. 2c). Such a polyion complex formed a nano-particle with a size of 100-200 nm. In 
this particle, the fluorescence is quenched because of the high concentration. Phosphorylation 
of the peptide moiety decreases the cationic net charges of the peptide so that an electrostatic 
interaction between the lipid-type peptide and the fluorescence-labeled polyanion decreases 
and this leads to the disintegration of the polyion complex. Such an event leads to an increase 
in the fluorescence intensity by several fold. In this system, the peptide substrate does not 
require the direct labeling of a fluorophore, which sometimes affects the ability of the molecule 
to act as a kinase substrate. This system was successfully applied to validate kinase inhibitors.  
4. Protein kinase assay based on fluorescent polarization 
Fluorescence polarization is a technique to detect the rotational property of a target 
molecule. When a fluorescent molecule is excited with polarized light, the extent of the 
remaining polarization of the emitted light depends on the rotation of the molecule. If the 
molecule rotates within the period of its excitation, the emitted light loses the polarization in 
the plane of excited light. Since the molecular rotation is dependent on the molecular weight 
of the protein, the technique can detect the binding of a large molecule to the target 
molecule. This strategy can be applied in the design of protein kinase assays. Seethala et al. 
1997 reported the first kinase assay based on a fluorescence polarization experiment 
(Seethala, 1997). Once a fluorescently labeled peptide substrate is phosphorylated with a 
protein kinase, an anti-phospo-amino acid antibody binds to the substrate (Fig. 3a). Due to 
the dramatic increase of the molecular size, the fluorescence polarization signal was 
observed to increase because of a reduction in the rate of rotation. This direct monitoring of 
fluorescence polarization is simple, but it usually requires a relatively large amount of anti-
phospho antibody. The method also needs a small substrate such as a peptide and the 
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technique cannot be applied using a protein substrate. On the other hand, if the strategy 
involves a competition assay, the protein substrate can also be available (Seethala et al., 
1998; Kristjansdottir et al., 2003) (Fig. 3b). In this system, after the protein substrate is 
phosphorylated by the protein kinase, it is added into the complex of the fluorescence-
labeled phosphorpeptide and anti-phopho antibody to compete for binding to the antibody. 
Thereafter, we can evaluate the kinase activity by evaluating the decrease in the fluorescence 
polarization signal. The advantage of the fluorescence polarization assay is that this 
approach is independent of the concentration or fluorescence intensity of the fluorophore 
used. However, only an anti-phospho antibody for tyrosine is available. Therefore, another 
molecule that can bind to phosphoserine or threonine is needed if this type of assay is to be 
applied to monitor the activity of serine/threonine protein kinases. Polycationic peptides 
and trivalent cation-containing particles can be used for this purpose (Coffin et al., 2000). 
However, such compounds have poor specificity. Moreover, polycationic peptides are also 
limited to the use of neutral substrate peptides and trivalent cation-containing particles 
sometimes suffer from weak binding to phosphorylated sites. The Phos-Tag may be another 
practical possibility because of its relatively high specificity and binding constant. Recently, 
a fluorescent polarization assay was applied to a high-throughput assay for screening 
inhibitors of a protein kinase (Kumar et al., 2011). 
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(a) Basic concept of protein kinase assay base on fluorescence polarization 
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(b) Protein kinase assay base on fluorescence polarization by using protein substrate 
Fig. 3. Protein kinase assay based on fluorescence polarization 
5. Use of FRET for protein kinase assay 
Fluorescence resonance energy transfer (FRET) is the non-radiation energy transfer between 
two different fluorophores. If the emission spectrum of the donor fluorophore and the 
excitation spectrum of the acceptor fluorophore overlap and these two fluorophores exist in 
close proximity, the excitation light for the donor produces an emitted light derived from 
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the acceptor. This phenomenon can be observed when the two molecules exist within 10 nm. 
Consequently, FRET is highly sensitive to distances between donors and acceptors. This 
methodology can be applied to similar systems characterized by fluorescence polarization-
based assays using peptide substrates and an anti-phospho antibody. If the peptide 
substrate and the antibody are labeled with acceptor and donor molecules, respectively, 
binding of the antibody to the phosphorylated substrate generates FRET between the donor 
and acceptor. Therefore, protein kinase activity can be detected by monitoring the ratio of 
the fluorescence intensity at two emission wavelengths for the donor and acceptor. FRET 
measurements are sometimes disturbed by background fluorescence derived from other 
biomaterials and are also affected by direct excitation of the acceptor with excitation light for 
the donor molecule. To avoid such disturbances, time-resolve FRET is often used. Riddle et 
al. 2006 reported a FRET system using a GFP-fused peptide substrate and an anti-
phosphotyrosine antibody labeled with a terbium ion complex (Riddle et al. 2006 (fig.4a)). 
The time-resolved FRET technique can be applied because rare earth metal complexes, such 
as terbium or europium complexes, produce long life-time fluorescences. However, a GFP 
fusion sometimes disturbs the phosphorylation of the substrate because of its large size. To 
avoid this effect, small organic fluorophores such as Alexa dyes are also used as acceptors 
(Zhang et al., 2005). A microplate based-high throughput assay has also been reported using 
a FRET-based kinase assay (Gratz et al., 2010) (Fig. 4b). In this assay, the substrate peptide of 
casein kinase 2 was labeled with fluorophore (EDANS) and the quencher (DABSYL) at the C 
and N terminus, respectively. The fluorescence of EDANS was quenched due to the FRET 
with DABSYL. Phosphorylation of the peptide by CK2 prohibited the cleavage of the 
peptide with elastase. Thus, CK2 activity was evaluated by the decrease in fluorescence. 
This approach was applied to a microplate-based assay and CK2 inhibitors were screened.     
Although these systems are applied only to solution samples, if a FRET system can be 
applied to living cells, it has an advantage of ratiometry, in which, the assay can be 
performed independent of the thickness of the sample. Phocus is a good example of such a 
system. In this probe, CFP and YFP are fused with a kinase substrate, linker and phosphor-
recognition domain (Sato & Umezawa, 2004) (Fig. 4c). In the free form, FRET between CFP 
and YFP does not occur because of the long distance between the two molecules. On the 
other hand, phosphorylation of the substrate domain causes the binding of the phosphor-
recognition domain. This moves the two fluorophores into close proximity to cause FRET. 
Using this probe, activities of c-Jun and Src were observed successfully in living cells. The 
advantage of this probe is that the probe can be expressed in living cell spontaneously after 
the transfection of the encoding genes. On the other hand, optimization of the construct is 
required to design the probe for each kinase, and the large fluorescence moieties, CFP and 
YFP, may disturb the access of the protein kinase to the substrate domain in some cases. The 
method is also inconvenient for HTS systems. 
An additional monitoring system of protein kinases uses an alpha-screen assay (Pedro et al., 
2010). Alpha-screening is not exactly a FRET system, but the excitation energy of a donor 
bead transfers to an acceptor bead indirectly via singlet oxygen. Excitation of the donor 
produces singlet oxygen with a photodynamic effect. Although the lifetime of singlet 
oxygen is very short, 4 sec, if the acceptor exists within 200 nm from the donor, the singlet 
oxygen can reach the acceptor. The acceptor then produces an emission light with singlet 
oxygen. Pedro et al. 2010 reported the monitoring of a leucine-rich repeat kinase (LRRK2), 
which is sometimes active in Parkinson’s disease, using the alpha-screen system. Moesin is a 
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substrate of LRRK2 fused with a GST tag. Donor and acceptor beads were modified with 
GST and protein A, respectively. An antiphospho-antibody was then introduced onto the 
acceptor bead through protein A. After the phosphorylation of moecine with LRRK2, the 
donor and acceptor beads bound the moecine through GST and the phosphorylation site, 
respectively. In this case, excitation of the donor bead with 680 nm light produced an 
emission light at 520600 nm from the acceptor bead through singlet oxygen. The system 
was applied to HTS analysis using a 384-well plate. 
The QTL Light Speed Kinase Activity AssayTM is also a sensitive detection system for detecting 
protein kinase activity (Moon et al., 2007). This assay uses a highly fluorescent microsphere 
and quencher-labeled substrate peptide. The peptide can bind to the microsphere if the 
peptide is phosphorylated by the target kinase, because its surface is modified with a gallium 
complex. The fluorescence of the microsphere is then quenched with the quencher on the 
peptide. The system was used in a HTS method involving a microarray. 
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(a) Conceptual design of Phocus which is FRET based kinase probe for intracellular imaging 
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(b) FRET assay of protein kinase for high throughput inhibitor screening 
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(c) Protein kinase assay based on time resolved FRET measurement 
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(d) Protein kinase assay based on alpha-screen assay 
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Fig. 4. FRET-based protein kinase assays 
6. HTS assay using Gold Nano-Particle (GNP) with colorimetry 
Although fluorimetry is sensitive and flexible, it can be affected by factors such as 
background substances, temperature, pH and the concentration of the fluorophore. 
Colorimetry, on the other hand, is simple and robust. We reported a label-free kinase assay 
using gold nano-particle (GNP) (Oishi et al., 2007; Oishi et al., 2008) (Fig. 5). Cationic 
peptides causes an aggregation of anionic GNP prepared by citrate reducing. This changes 
the color of the GNP dispersion from red to blue. This aggregation is highly sensitive to the 
peptide. Cationic peptide aggregates are 1000-fold more effective than inorganic cations that 
have same cationic charges. However, if the peptide is phosphorylated by the target kinase, 
the ability to aggregate is reduced dramatically so that the color of the dispersion remains 
red upon the addition of the peptide. Thus, phosphorylation of the peptide can easily be 
detected by monitoring the absorbance at 670 nm. The assay has been sufficiently sensitive 
to detect PKA, PKC, MAPK, p38 and Src activity in solution, cell lysates and tissue 
extracts. Detection of PKC activity in tumor and normal tissues from human patients 
suggests that the assay can be applied as a diagnostic of breast cancer (Kang et al., 2010). The 
assay was also used to screen for protein kinase inhibitors using a micro-titer plate format 
(Oishi et al., 2008; Asami et al., 2011). Using a chemical library containing 3000 chemicals, 
new PKA inhibitors, which have similar inhibitory activity to current PKA inhibitors, were 
actually identified using this assay. The aggregation of GNP is affected by the cationic net 
charges of the peptide and ionic strength. Therefore, the ionic concentration of the detecting 
solution has to be optimized for each peptide sequence. However, such conditions can be 
optimized easily, because the conditions of the phosphorylation and detection steps can be 
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set independently. In addition, this assay does not require any labeling steps to the substrate 
peptide and is simple, rapid and widely applicable from solution to tissue samples. Since 
the assay depends on decreasing net charge of the substrate peptide, the original net charge 
has to be cationic. On the other hand, some protein kinases require anionic peptide 
sequences as their substrates. This issue can be overcome by the addition of some cationic 
amino acids at one end of the peptide through a flexible triethylene glycol linker. If gold 
nano-rods are covered with a cationic surfactant, Cetyltrimethylammonium bromide 
(CTAB) is used instead of GNP, and an anionic substrate can be used without any addition 
of cationic amino acids (Kitazaki et al., 2011). 
- - -
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-
-
-
-
-
-
Anionic gold nano-particle
Cationic substrate peptide
Phosphorylated peptide
Aggregation: blue
Dispersion: red  
Fig. 5. Concept of colorimetrical assay of protein kinase using gold nano-particle 
7. Peptide array 
Genomic and post-genomic research has enabled us to understand life at the molecular 
level. Many aspects of molecular processes have been elucidated. As a result, evolutionary 
changes have been made in methodologies in drug discovery, diagnostics and other medical 
technologies. Developments of molecular targeted drugs that primarily target tyrosine 
kinases for cancer therapy represent a typical example. However, life was not constructed 
through a simple combination of such pieces, but involves many pieces that interact with 
each other to generate a complicated network system. Therefore, diseases are not simply 
treated by inhibiting a single target molecule. For example, cancer cells often acquire a 
tolerance against molecular targeted drugs during their applications, even though the drugs 
continue to inhibit the target protein kinases. Therefore, we have to clarify the condition of 
entire signal network to know the cellular condition exactly. From research using gene chip 
technology, it has been clarified that a major part of the transcriptome is necessary to 
maintain the basic functions of living cells, and only a part of the transcriptome relates to 
each cell-specific function. Tiny fluctuations of the transcriptome sometimes cause a 
significant change in the enzymatic network determining cell function (Irish et al., 2004). 
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This indicates that monitoring enzymatic activities in cellular signal transduction events 
must be efficient and effective for precisely evaluating cell conditions. Kinome, the entire 
profile of protein kinases in cells, is a new concept presented in this issue. The most practical 
format of the kinome analysis is peptide array. Peptide array involves chip technology, in 
which many peptide substrates of protein kinases are immobilized on a solid support. Some 
peptide array systems are now commercially available. The PepScan array is probably the 
first example in which kinome analysis was carried out using a peptide array (Diks et al., 
2004). In this array, many peptide substrates are immobilized onto a glass slide and 
phosphorylation is detected with the incorporation of [33P]-phosphate from RI-labeled ATP. 
Using the array immobilizing 192 peptides, changes in the activities in particular kinases 
after LPS stimulation was analyzed. Following this report, kinome in Barrett’s esophagus, 
endothelial cells and also c-Met activity in colon cancer after the inhibition of 
cycloocygenase-2 were monitored using more than 1000 peptides (van Baal et al., 2011). 
Although the array seems to give reasonable evaluations in activation of particular kinases, 
the system assumes that one peptide is phosphorylated by a single kinase; however, such 
short peptides may be phosphorylated by plural protein kinases. The CelluSpot system is 
another similar peptide array format (Olaussen et al., 2009). In this array, peptide substrates 
that were synthesized on a nitrocellulose membrane are cleaved and set on a solid support. 
The effect of tyrosine kinase inhibitors on the kinome in a carcinoma cell line was evaluated 
using this system with 144 peptides. Phosphorylation of the peptides was detected using a 
fluorescence-labeled anti-phosphotyrosine antibody. Although this system is simple and 
does not use radio-active material, the size of each spot is large (1 mm) such that a relatively 
large amount of sample is required.  
Enzymatic reactions are sometimes inconvenient to perform on solid surfaces. The Pamchip is 
an array to address this issue (Jinnin et al., 2008; Maat et al., 2009). In this system, peptides are 
immobilized in a well consisting of porous material. The porous material is 60 m thick and 
has long branched interconnected capillaries with a diameter of 200 nm. It results in a 500-fold 
increase in the reactive surface and the reaction and washing steps can also be performed by 
pulsing back and forth through the porous material many times. The profile of tyrosine kinase 
activities in a pediatric brain tumor was evaluated and compared with kinomes from other 
various cancer cell lines in 144 peptides (Sikkema et al., 2009). A group of peptides that were 
phosphorylated by all cancer cell lines and by particular cell lines were identified. However, it 
is relatively difficult to identify each kinase from such profiles. Activation of vascular 
endothelial growth factor receptor type2 (VEGEFR2) and Src signaling were also confirmed 
in infantile hemangioma and melanoma cells, respectively, with this system. 
The above mentioned peptide arrays are useful for kinome analysis. However, it is unclear 
whether they can be used for quantitative analysis. For monitoring kinase activity, it is 
important to know how much activity has changed. In many cases, cellular function will be 
influenced by the degree of activation of particular kinases. Recently we developed a peptide 
array in which peptide substrates are immobilized onto gold or glass support for surface 
Plasmon resonance (SPR) and fluorescence detection, respectively (Shigaki et al., 2007; Inamori 
et al. 2005) (Fig. 6a). By careful optimization of the surface chemistry, these arrays secured 
quantitative data describing the detection of the phosphorylation ratio in each peptide (Han et 
al., 2008; Shimomura et al., 2011). For example, the efficiency of peptide immobilization 
influenced the results from the methodology (Inamori et al., 2008) (Fig. 6b).  
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Fig. 6. Quantitative peptide array: concept and immobilization method of peptide substrate 
Figure 6b shows the efficiency of peptides immobilized onto a gold chip. Although the 
polyethylene glycol (PEG) moiety is effective in suppressing non-specific adsorption of bio-
substances, peptide immobilization was also suppressed if the PEG moiety was modified on 
the chip in advance. On the other hand, when the PEG-linked peptide was reacted with a 
rigid group on the chip, the amount of the immobilized peptide increased dramatically. In 
our system, phosphorylation of the peptide was achieved by using an anti-phosphotyrosine 
antibody or PhosTag molecules followed by the addition of streptavidin. Changes in the 
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activities of particular protein kinases were detected using the SPR chip in solution and a 
cell lysate after the cell was stimulated with NGF (Han et al., 2009). An advantage of the SPR 
detection system is that it does not require any labeling for detection. However, this 
advantage contains a risk that binding of any other substances gives rise to a detectable 
signal at the same time. In this case, fluorescence detection will be more practical. In the 
quantitative detection of the kinome on a peptide array, peptides that have cysteines at the 
amino terminus were immobilized through a formyl group or maleimide. In the former 
case, high-density amino-modified glass surfaces were treated with glutaraldehyde, and 
then the peptide was linked to the formyl group at the thiol group of the cysteine residue by 
forming a thiazoline ring (Mori et al., 2009). The surface of the chip was then blocked from 
unspecific adsorption with Blocking One-P, which is a commercial cocktail. We recently 
used a plastic plate that was modified, called the ‘S-Bio’ system, to avoid the adsorption of 
biomacromolecules. In this case, cysteine-containing peptides were immobilized on the chip 
using maleimide chemistry. Detection of phosphorylation was achieved using a Cy-3 
labeled anti-phosphotyrosine antibody or a PhosTag and Alexa647-labeled streptavidin. 
After the optimization of the conditions of immobilization, the obtained chip provides 
quantitative phosphorylation ratios of the peptide. This quantitative analysis is sufficient for 
measuring peptide phosphorylation immobilized on a single chip. However, an internal 
standard is required for the inter-plate comparison. Alexa647 labeled peptide is used for this 
purpose. Using this array, Src activity in various cancer cell lines and mouse tissues was 
successfully monitored. Changes in the kinome profile with drug stimulation such as NGF 
or Iressa was also obtained (Han et al., 2010). Such arrays were also applied to screen kinase 
inhibitors (Inamori et al., 2009). 
Kinome analysis using peptide array has not been a well-establish technology. Especially, 
bio-informatics technique which converts obtained phosphorylation profile into actual 
signal network of protein kinases. Reproducibility of peptide array has also to be improved. 
8. New technology using protein kinase activity in artificial bio-regulation 
As mentioned above, many technologies for monitoring protein kinase activity have been 
developed. On the other hand, any technology that uses protein kinase activity should also 
be useful for medicine, because protein kinases play key roles in determining cellular 
functions. Abnormal activation of particular kinases is often observed in many diseases. For 
example, hyper-activation of EGFR, c-MET, bcl-Abl, PKC, or Src has been reported in 
many types of tumors. In myocardiac infarction, over expression of Rho kinase is also 
reported. Activation of I--kinase is a key signal to initiate inflammation. Therefore, 
abnormal activity of such kinases can be markers to distinguish disease cells. In this context, 
if these signals can be converted to other information artificially, such signal conversion 
should identify disease cells specifically. Such artificial signal converters will offer a new 
strategy for cell-specific medicines. We recently reported some artificial gene regulators that 
activated transgene expression in response to target protein kinase activity (Oishi et al., 2006; 
Sonoda et al., 2005; Kawamura et al., 2005) (Fig.7). The regulators consist of polymer 
backbone and some cationic peptide side-chains. The peptide is also designed as a specific 
substrate of a target protein kinase. Since the polymer-peptide conjugates are polycationic, 
they can form electrostatic complexes with DNA such as an expression vector. In the 
complex, this type of conjugate suppresses the gene transcription much more efficiently  
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Fig. 7. Structure of artificial gene regulator (left) and concept of its gene regulation in 
response to protein kinase 
than ordinary polycations such as polyethyleneimine, or poly-L-lysine. When the complex is 
taken up by target disease cells in which target protein kinases are hyper-activated, the 
peptide side-chains are phosphorylated. This introduction of anionic charges decreases the 
net cationic charges of the conjugate, and the electrostatic interaction between the conjugate 
and DNA is attenuated. As a result, the gene can be expressed due to the disintegration of 
the complex. This system is the first strategy for cell-specific gene therapy using kinase 
activity as a marker of cellular identification. Using this strategy, various gene regulators 
have been developed for Src, PKC, I--kinase, Rho kinase and PKA as target signals (Sato 
et al., 2010; Kang et al., 2010; Asai et al., 2009; Tsuchiya et al., 2011; Oishi et al., 2006). These 
materials realize highly cell-specific gene expression. Figure 8b indicates examples of such 
signal-responsive gene expression in I--kinase and PKC-responsive systems (Asai et al., 
2009). The I--kinase responsive system activated expression of a GFP encoding gene only 
following stimulation of NHI 3T3 cells with LPS or TNF-, thereby initiating inflammation. 
However, if the serine residue in the peptide side-chain, which is a phosphorylation site, 
was replaced with alanine, such gene expression was not observed even following 
stimulation by LPS or TNF-. PLC is another important kinase for the proliferation of 
many types of cancer cells (Kang et al., 2009). Therefore, transfection of GFP encoding 
plasmid as a complex with the PKC responsive regulator gave massive expression of GFP 
in various cancer cell lines (Asai et al., 2009). Conversely, a negative control-regulator, in 
which the serine residue was replaced with alanine, did not show any expression in such 
cell lines. In addition, no activation of GFP expression was observed when such cells were 
pre-treated with an inhibitor of PKC. These results clearly indicate that such systems 
regulated gene expression in response to target kinases (Toita et al., 2009). In particular, the 
PKC responsive system worked also in tumor bearing mice (Kang et al., 2008; Toita et al., 
2009; Kang et al., 2010) (fig. 8c). When a complex between a PKC-responsive conjugate and 
the luciferase encoding gene was injected into a tumor directly, expression of luciferase was 
observed successfully. On the other hand, injection of the complex in normal subcutaneous 
tissue or injection of the complex using a negative control conjugate into a tumor did not 
show any expression of luciferase. The obtained image of luciferase indicates a proliferation 
activity, because the enzymatic activity regulates cancer proliferation directly and is closely 
related to the cancer malignancy. Thus, this system will be useful for cancer imaging, 
because this is the first functional imaging of cancer in contrast to ordinary imaging 
techniques of cancer that mainly visualize the existence of a tumor. Such functional images 
should provide much more sharpshooting information for prognosis than currently used 
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imaging technologies. Such a system can also be applied to cancer cell-specific gene therapy 
(Tomiyama et al., 2010 and 2009). Using the caspase-8 encoding gene as a therapeutic gene, 
shrinkage of the tumor was also observed in HepG2 tumor bearing mice. HSV thymidine 
kinase encoding gene and the gancyclovir system also worked well in this system. Since this 
method is highly disease cell-specific, gene activity can be masked in other normal tissues or 
organs due to the absence of continuous target kinase activity (Kang et al., 2010). Therefore, 
many therapeutic genes, which were abandoned as clinical targets because of their side 
effects derived from undesired activation of such genes in non-target organs, should be 
revived using this methodology. These techniques are potentially useful for future 
medicines; although the gene complex has to be stabilized in blood flow. By covering the 
complex with sugar chains such as chondroitin sulfate or hyaluronic acid offers a promising 
way to access this issue (Tomiyama et al., 2011). 
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Fig. 8. Intracellular protein kinase-responsive gene regulation system 
9. Conclusion and future prospective 
Recent technologies for the monitoring or handling of protein kinase activities have been 
described. Monitoring protein kinase activities using current technologies offers a way to 
understand basic biological processes of life. Such technologies are becoming significant in 
medical and medicinal fields, because protein kinases represent major drug targets and can 
also be used as diagnostic markers. However, such technologies have to be high-throughput 
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to satisfy medical or pharmaceutical demands. Detecting dysfunctional activity of particular 
kinases and relating this to a disease condition will require the development of simple and 
rapid assays. Fluorescence polarization, bead techniques using fluorimetry and colorimetric 
assays offer a way to reach this goal. Mass spectrometry is also a promising approach (Kang 
et al., 2008; Kang et al., 2007; Shigaki et al., 2006). Peptide arrays are another promising 
technology for detail evaluation of cellular conditions. Since cellular function is determined 
by a network of signaling reactions governed by enzymes including protein kinases, the 
exact state of living cells in various diseases cannot be evaluated by a single protein kinase 
assay. In this context, kinome analysis will be crucial for providing a detailed diagnosis 
before medication, prognosis after medication and validation of drugs in pharmaceutical 
testing. However, problems with the current peptide array systems, including their low 
reproducibility of obtaining similar phosphorylation profiles on chips, are hampering 
progress towards fully accurate kinome analysis. Relatively low specificity of peptide 
substrates is another issue. It is difficult to convert the obtained phosphorylation profile into 
a profile that represents the actual protein kinase activity. Bioinformatics and mathematical 
technology should be combined with array technologies in the future. 
Protein kinases are also attractive as a marker to distinguish between disease cells and 
normal cells. Our gene regulation system that responds to target protein kinase activity is 
the first artificial system that uses intracellular signaling as a trigger to output another 
biological signal. Such signal engineering represents a new cell-specific medicine approach. 
We need such a new technological field, termed “Cell Signalomics”, to link basic biological 
findings to clinical approaches. Protein kinases will be one of the most important elements 
for such a technology. 
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